Advertisement

Topics

Companies Related to "Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets" [Most Relevant Company Matches] RSS

01:00 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets" found in our extensive corporate database of over 50,000 company records.

Showing "Determination Variances Exhaled Nitric Oxide Output Normal Healthy" Companies 1–25 of 1,000+

Extremely Relevant

NicOx SA

NicOx aims to achieve profitability and growth through the research and development of nitric oxide therapeutics. NicOx begins its development process by taking well-known drugs and enhancing them with nitric oxide-releasing structures resulting in patentable new chemical entities.


GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...

Medinox, Inc.

Medinox is a leader in anti-nitric oxide therapeutics and is developing a broad technology platform to address several unmet medical needs including hemodialysis, cardiopulmonary bypass surgery and septic shock. In addition to its nitric oxide technology, Medinox is also developing new and safer NSAID prodrugs for treating arthritic patients. For information about Medinox and its products, please ...


GeNOsys, Inc.

GeNOsys, Inc. (generated nitric oxide systems) is a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems. Nitric oxide gas will be one of the medical gases that will be generated along with various combinations of beneficial medical gases suitable for the control of human disease. Distribu...

Apieron, Inc.

Apieron, Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. ...

Relevant

NantOmics, LLC

NantOmics, a member of the NantWorks ecosystem of companies, delivers molecular analysis capabilities with the intent of providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at the point of care. NantOmics is the first molecular testing company to pioneer an integrated approach to unearthing the ...

NantOmics LLC

NantOmics LLC, is a leading medical diagnostic company dedicated to providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at point of care. NantOmics is the first molecular diagnostics company to pioneer an integrated approach which unearths the genomic and proteomic variances that initiate and dr...

NeurAxon, Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

NeurAxon Inc.

NeurAxon, Inc. (www.neuraxon.com) discovers and develops next-generation pain therapeutics focused on its first-in-class selective inhibitors of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.

Medinox, Inc

Medinox, Inc. is a San Diego-based pharmaceutical company that is developing new small molecule drugs to treat a wide variety of unmet medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The Company's research and clinical development programs fall into two broad categories: 1) nitric oxide neutralizers, and 2) novel prodrugs.

Cellegy Pharmaceuticals

Cellegy Pharmaceuticals, Inc. is a specialty biopharmaceutical company engaged in the development and commercialization of prescription drugs including topical treatments for anal fissures and hemorrhoids and hormone replacement therapy for men and women. We recently expanded our research to include other potential products based on nitric oxide pharmacology through the acquisition of Vaxis Therap...

vasopharm GmbH

vasopharm is a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases and their consequences – indications with significant unmet clinical need. The company is focused on the development of therapeutics which steer the availability of biological nitric oxide (NO) over the entire NO signal cascade and its f...

Arginox Pharmaceuticals, Inc

Arginox Pharmaceuticals is an emerging specialty biopharmaceutical company focusing on the discovery and development of breakthrough drugs for treating hospitalized patients. The company's initial area of research is directed at nitric oxide (NO), which has been shown in Nobel prize-winning research to play a role in a range of physiologic functions. Arginox is leading the way in developing drugs ...

CRYSTAL RESEARCH

Knowledge of a protein's 3D structure is essential for understanding its function and the precise interaction between a drug and its receptor. The major bottleneck of crystal structure determination is obtaining crystals good enough for X-ray diffraction experiments. Crystal Research is dedicated to helping you speed up the structure determination of your target molecules. By using proprietary tec...

Alexis Biochemical

ALEXIS, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions Growth Factors, Cytokines & Chemokines Immunology & Cancer Research Neurochemicals Nitric Oxide & Oxidative Stress Signal Transduction & Cell Trafficking Over the years ALEXIS Corporation has developed a substant...

NicOx S.A

NicOx is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs.NicOx is targeting the therapeutic areas of inflammation and cardiovascular disease.The Company’s resources are focused on its two lead compounds in late stage development for the treatment of osteoarthritis and Peripheral Arterial Obstructive Disease (PAOD)...

Alexis Corporation

ALEXIS Corporation, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions Growth Factors, Cytokines & Chemokines Immunology & Cancer Research Neurochemicals Nitric Oxide & Oxidative Stress Signal Transduction & Cell Trafficking Over the years ALEXIS Corporation has develope...

World Precision Instruments Ltd

WPI Inc began in 1962 as a small manufacturer of amplifiers and stimulators used in nerve, skin and muscle research. More than 30 years later, we have grown to become the world leader in TEER measurement, nitric oxide sensing and more. In 1990 we moved from our original home in New Haven, Connecticut, to Sarasota, Florida. As worldwide demand for WPI products increased, offices were opened in Lond...

SynZyme Technologies, LLC

SynZyme Technologies, LLC ("SynZyme" or the "Company"), is a privately held drug discovery and development Company founded in 1998 that researches and develops pharmaceutical candidates through Phase II clinical trials, prior to licensing them to pharmaceutical companies for further development, manufacturing and marketing. The Company works closely with research collaborators at leading instituti...

AOBiome

AOBiome LLC is developing a transformative, new class of products based on Ammonia Oxidizing Bacteria (AOB) to improve skin health and prevent or treat skin and inflammatory diseases. The company’s probiotics are designed to provide cosmetic and therapeutic benefits by restoring the natural, protective balance afforded by beneficial skin microbes that ...

U.S. Genomics

U.S. Genomics is pioneering tools to enable single molecule biology for the life sciences industry. The company develops and manufactures instruments and their associated reagents for researchers in academia, pharmaceutical and biotech companies, and contract research organizations. U.S. Genomics has introduced the Trilogy™2020 single molecule analyzer, a bench-top instrument, combining advance...

Nuvilex, Inc.

Nuvilex, Inc. is a “Green” products company. The Company’s current products include: Cinnergen™, which promotes a healthy glucose metabolism; Cinnechol™, designed to help maintain normal cholesterol levels and support normal cardiovascular function; and Infinitink®, a permanent yet more easily removable tattoo ink. In early March, 2010...

Ikaria Holdings Inc.

Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Latin America and Austral...

Biotrend Chemikalien GmbH

BIOTREND offers more than 5.000 mono- polyclonal antibodies for research and diagnosis. A vast number of secondary antibodies labeled to AP, Biotin, Colloidal Gold, Cyan, FITC, HRP, PE, Texas RedTM and TRITC are available. You will find them under "Immunoglobulin......" in our database. Ready to use substrate solutions and fizzing tablets for the visualisation are also available.The range of Neuro...

Medinox

Medinox, Inc. is a San Diego-based emerging pharmaceutical company that is developing new small molecule drugs of large revenue potential and tremendous scope. Our goal is to become a premier pharmaceutical company by commercializing new medicines for inflammatory diseases and disorders that save lives and improve the quality of life. To achieve this, we are developing three core pharmaceutical te...


More From BioPortfolio on "Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks